Pilot scale purification of human monoclonal IgM (COU-1) for clinical trials
- 1 June 1997
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 205 (1) , 11-17
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Purification and immunochemical characterization of a natural human polyreactive monoclonal IgM antibodyJournal of Immunological Methods, 1994
- Purification of two murine monoclonal antibodies of the IgM class by hydroxylapatite chromatography and gel filtrationBiomedical Chromatography, 1993
- Effect of Culture Conditions on IgM Antibody Structure, Pharmacokinetics and ActivityBio/Technology, 1993
- Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumourEuropean Journal of Nuclear Medicine and Molecular Imaging, 1992
- Characterization of a Human—Human Hybridoma Antibody, C-OU1, Directed Against a Colon Tumor-Associated AntigenHybridoma, 1992
- Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Purification of a murine monoclonal antibody of the IgM classJournal of Immunological Methods, 1991
- Purification of Monoclonal Antibodies by Hydroxylapatite HPLC and Size Exclusion HPLCBiological Chemistry Hoppe-Seyler, 1991
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatographyJournal of Immunological Methods, 1985